PT101175A - Metodo para a preparacao de comprimidos de resistencia aumentada e comprimidos assim obtidos - Google Patents

Metodo para a preparacao de comprimidos de resistencia aumentada e comprimidos assim obtidos

Info

Publication number
PT101175A
PT101175A PT101175A PT10117593A PT101175A PT 101175 A PT101175 A PT 101175A PT 101175 A PT101175 A PT 101175A PT 10117593 A PT10117593 A PT 10117593A PT 101175 A PT101175 A PT 101175A
Authority
PT
Portugal
Prior art keywords
pills
preparation
increased resistance
tablets
binder
Prior art date
Application number
PT101175A
Other languages
English (en)
Other versions
PT101175B (pt
Inventor
Julian Belknap Lo
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT101175A publication Critical patent/PT101175A/pt
Publication of PT101175B publication Critical patent/PT101175B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT101175A 1992-01-13 1993-01-11 Metodo para a preparacao de comprimidos de resistencia aumentada e comprimidos assim obtidos PT101175B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81955392A 1992-01-13 1992-01-13

Publications (2)

Publication Number Publication Date
PT101175A true PT101175A (pt) 1994-03-31
PT101175B PT101175B (pt) 1999-09-30

Family

ID=25228458

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101175A PT101175B (pt) 1992-01-13 1993-01-11 Metodo para a preparacao de comprimidos de resistencia aumentada e comprimidos assim obtidos

Country Status (12)

Country Link
US (1) US5853758A (pt)
EP (1) EP0620728B1 (pt)
JP (1) JP2640570B2 (pt)
AT (1) ATE147261T1 (pt)
CA (1) CA2117351C (pt)
DE (1) DE69216642T2 (pt)
DK (1) DK0620728T3 (pt)
ES (1) ES2096103T3 (pt)
FI (1) FI109086B (pt)
GR (1) GR3022458T3 (pt)
PT (1) PT101175B (pt)
WO (1) WO1993013758A1 (pt)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
ES2076106B1 (es) * 1993-08-26 1996-06-16 Pfizer Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas
CA2186785A1 (en) * 1994-04-01 1995-10-12 Yoichiro Nakai Process for producing sustained-release tablets and enteric tablets
DE69628007T2 (de) * 1995-06-07 2003-11-27 Elan Drug Delivery Ltd., Ruddington Verfahren zur stabilen einarbeitung von substanzen in trockene geschäumte glasmatrizen und auf diese weise hergestellte zusammensetzungen
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
RU2123330C1 (ru) * 1997-04-02 1998-12-20 Фармацевтическая фирма "Здоровье" Способ получения таблетированной формы препарата
US6413541B1 (en) 1999-01-13 2002-07-02 Dainippon Pharmaceutical Co., Ltd. Disintegrating tablet in oral cavity and production thereof
JP4504467B2 (ja) * 1998-07-30 2010-07-14 佐藤製薬株式会社 口腔内崩壊性錠剤
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB2350582A (en) * 1999-06-01 2000-12-06 Hiran Asoka Malinga Ratwatte A method of tableting
US6277409B1 (en) 2000-02-11 2001-08-21 Mcneil-Ppc, Inc. Protective coating for tablet
US6258381B1 (en) 2000-02-11 2001-07-10 Mcneil-Ppc, Inc. Tablet and process for making the same
US20020015730A1 (en) * 2000-03-09 2002-02-07 Torsten Hoffmann Pharmaceutical formulations and method for making
US20020001617A1 (en) * 2000-05-26 2002-01-03 Chang-Hyun Lee Rapidly disintegrating tablet and process for the manufacture thereof
US20100015246A1 (en) * 2000-06-27 2010-01-21 Shire International Licensing B.V. Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
CA2350195C (en) * 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
EP1226818A1 (en) * 2001-01-26 2002-07-31 Pfizer Products Inc. Pharmaceutical dosage forms with enhanced cohesive and compressibility properties
DK1389102T3 (da) * 2001-04-23 2011-06-06 Shire Int Licensing Bv Anvendelse af lanthancarbonat til forebyggelse af nyresten
AU2002255321B2 (en) * 2001-05-10 2007-05-17 Astellas Pharma Inc. Tablets quickly disintegrating in the oral cavity and process for producing the same
US6872405B2 (en) 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
RU2266744C2 (ru) * 2001-06-21 2005-12-27 Duchesnay Ink. Композиция быстрого начала действия
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US7914811B2 (en) 2001-06-29 2011-03-29 Mcneil-Ppc, Inc. Brittle-coating, soft core dosage form
EP1429745A2 (en) 2001-09-28 2004-06-23 McNEIL-PPC, INC. Composite dosage forms having an inlaid portion
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
WO2003068604A1 (en) * 2002-02-13 2003-08-21 Weibel Michael K Drug dose-form and method of manufacture
GB0204772D0 (en) * 2002-02-28 2002-04-17 Phoqus Ltd Pharmaceutical dosage forms
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
DK2172205T3 (da) * 2003-08-26 2014-07-14 Shire Biopharmaceuticals Holdings Ireland Ltd Farmaceutisk formulering bestående af lanthan-forbindelser
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US8591974B2 (en) * 2003-11-21 2013-11-26 Kraft Foods Global Brands Llc Delivery system for two or more active components as part of an edible composition
US8597703B2 (en) 2005-05-23 2013-12-03 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component
US8591968B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Edible composition including a delivery system for active components
US8591972B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for coated active components as part of an edible composition
US8389032B2 (en) 2005-05-23 2013-03-05 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition having selected particle size
US20050112236A1 (en) 2003-11-21 2005-05-26 Navroz Boghani Delivery system for active components as part of an edible composition having preselected tensile strength
US8591973B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for active components and a material having preselected hydrophobicity as part of an edible composition
KR101072196B1 (ko) * 2004-07-27 2011-10-10 샤이어 파마세우티컬, 인크. 란탄 하이드록시 카보네이트를 이용한 고인산증 치료 방법
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20070104799A1 (en) * 2005-11-09 2007-05-10 Shire International Licensing B.V. Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds
US20070207206A1 (en) * 2006-03-02 2007-09-06 Rice Bronwyn C Chewable pain formula
US20070259052A1 (en) * 2006-05-05 2007-11-08 Shire International Licensing B.V. Assay for lanthanum hydroxycarbonate
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
US20090068262A1 (en) * 2007-04-04 2009-03-12 Ilan Zalit Rapid dissolution of combination products
ES2633449T3 (es) 2007-10-31 2017-09-21 Johnson & Johnson Consumer Inc. Forma de dosis oralmente desintegrable
US8784781B2 (en) 2009-09-24 2014-07-22 Mcneil-Ppc, Inc. Manufacture of chewing gum product with radiofrequency
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
NZ600256A (en) 2009-12-02 2014-05-30 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
MX365710B (es) 2011-04-29 2019-06-11 Intercontinental Great Brands Llc Acido encapsulado, metodo para la preparacion del mismo y goma de mascar que comprende el mismo.
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
CN103432091A (zh) * 2013-09-13 2013-12-11 钟术光 一种性能改善的片剂及其制备方法
AU2015204763A1 (en) 2014-01-10 2016-07-21 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CN105769887B (zh) * 2014-12-23 2019-04-30 上海复星星泰医药科技有限公司 一种复方果糖二磷酸钠果糖口崩片及其制备方法
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
EP3389628A4 (en) 2015-12-19 2019-08-07 Dixit, Manesh A. PHARMACEUTICAL FORMULATIONS OF MOUSE CHEESE TABLETS
PL3576718T3 (pl) * 2017-02-01 2021-12-27 Johnson & Johnson Consumer Inc. Pastylka twarda
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
JP7145121B2 (ja) 2019-05-31 2022-09-30 信越化学工業株式会社 錠剤の製造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
NL297357A (pt) * 1962-08-31
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
DE1617593A1 (de) * 1965-10-12 1971-04-29 Leo Pharm Prod Ltd Verfahren zur Herstellung von Tabletten oder Pillen
US3487138A (en) * 1966-11-23 1969-12-30 Merck & Co Inc Process for preparing a delayed release medicinal tablet
US3653914A (en) * 1970-03-20 1972-04-04 Alberto Culver Co Production of tablets
FI53921C (fi) * 1971-06-04 1978-09-11 Boehringer Mannheim Gmbh Foerfarande foer granulering av tablettmassor i pulverform
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
JPS5031022A (pt) * 1973-05-29 1975-03-27
US3961004A (en) * 1974-04-11 1976-06-01 Auburn Research Foundation Method of tabletting using gluconolactone as the direct compression diluent
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
JPS58403B2 (ja) * 1975-07-24 1983-01-06 武田薬品工業株式会社 Ｌ− アスコルビンサンセイザイノ セイゾウホウ
DE2556561C2 (de) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
US4166107A (en) * 1978-07-25 1979-08-28 The United States Of America As Represented By The Secretary Of Agriculture Sustained release bolus formulations containing insect growth regulators for control of livestock pests
US4994227A (en) * 1986-03-10 1991-02-19 American Cyanamid Company Method for the preparation of sustained released bolus formulation
US4760094A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US5137669A (en) * 1988-03-02 1992-08-11 Endocon, Inc. Manufacture of partially fused peptide pellet
DE3812567A1 (de) * 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
LU87233A1 (fr) * 1988-06-07 1990-02-28 Pharlyse Sa Composition pharmaceutique a base d'un anti-inflammatoire non steroidien,son procede de preparation et son utilisation
US5036097A (en) * 1989-10-17 1991-07-30 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
AU657514B2 (en) * 1991-01-03 1995-03-16 Glaxo Canada Inc. Method for production of solid pharmaceutical preparation

Also Published As

Publication number Publication date
EP0620728A1 (en) 1994-10-26
PT101175B (pt) 1999-09-30
GR3022458T3 (en) 1997-04-30
DE69216642T2 (de) 1997-05-07
FI943327L (fi) 1994-07-12
JP2640570B2 (ja) 1997-08-13
CA2117351A1 (en) 1993-07-22
CA2117351C (en) 1998-03-03
FI109086B (fi) 2002-05-31
ES2096103T3 (es) 1997-03-01
DE69216642D1 (de) 1997-02-20
EP0620728B1 (en) 1997-01-08
DK0620728T3 (da) 1997-07-07
ATE147261T1 (de) 1997-01-15
WO1993013758A1 (en) 1993-07-22
US5853758A (en) 1998-12-29
FI943327A0 (fi) 1994-07-12
JPH07503237A (ja) 1995-04-06

Similar Documents

Publication Publication Date Title
PT101175A (pt) Metodo para a preparacao de comprimidos de resistencia aumentada e comprimidos assim obtidos
CA2152795A1 (en) Readily available konjac glucomannan sustained release excipient
FI943315A7 (fi) Farmaseuttinen valmiste pore- ja/tai hajoamistabletin tai pikarakeiden muodossa, samoin kuin menetelmä valmistaa niitä
MX10558A (es) Formulacion de matriz de liberacion sostenida y proceso para preparar un medicamento en tabletas.
NZ234587A (en) A chewable pharmaceutical tablet of compressed coated granules
DE69738300D1 (de) Pharmazeutische zusammensetzungen mit verzoegerter freisetzung, die wasserunloesliche komplexverbindungen enthalten
HUP0003121A3 (en) Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance
AU1252088A (en) Pharmaceutical composition, pharmaceutical granulate and process for their preparation
NL960028I1 (nl) ML-236B-derivaten, werkwijze voor hun bereiding enfarmaceutische preparaten, die deze derivaten bev atten.
IT8820145A0 (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
FI885398A7 (fi) Menetelmä stabiilin, puristetussa muodossa olevan farmaseuttisen koostumuksen valmistamiseksi
EP0729748A4 (en) METHOD FOR PRODUCING STABLE MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATION
DE3483508D1 (de) Physiologisch aktive substanz k-252, verfahren zu ihrer herstellung und eine pharmazeutische zusammensetzung die diese enthaelt.
GEP20033062B (en) Pharmaceutical Composition Comprising Entacapone or Nitecapone and Cross-Linked Cellulose Derivative
CA2093666A1 (en) Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
NL8601838A (nl) Distamycinederivaten, werkwijze voor de bereiding ervan, alsmede farmaceutische preparaten, die deze derivaten bevatten.
DE3477469D1 (en) Enzyme-protein conjugate, process for its preparation and pharmaceutical use thereof
IT1230703B (it) Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
JPS57130913A (en) Direct compress analgesic drug granulating composition, tablets thereof and manufacture
AU5139596A (en) Pharmaceutical matrix pellets, tablets and composition for the preparation thereof
GB2230262B (en) 2-substituted n,n-di-trimethoxybenzoyl piperazines and pharmaceutical uses thereof
HUT49873A (en) Herbicides and acaricides, as well as process for producing the active ingredient aryl- or heteroaryldione derivatives
HUT58068A (en) Process for producing new, pharmacologically active compounds and pharmaceutical composition comprising same as acvtive ingredient
NL192792B (nl) Cefalosporinederivaten, werkwijze voor hun bereiding en farmaceutische preparaten die een dergelijk preparaat bevatten.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930820

FG3A Patent granted, date of granting

Effective date: 19990624